Abstract 1143: Lenalidomide Is a Highly Effective Maintenance Therapy in Myeloma Patients of All Ages; Results of the Phase III Myeloma XI Study

The use of maintenance lenalidomide treatment results in highly significant improvements in PFS for patients of all ages and should be standard of care.

 American Society of Hematology 2016 Annual Meeting

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.